PRINTABLE
VERSION

CBD vs. THC flower: Why the price difference?

Cannabis Business Times

OUR TAKEAWAY

To answer the question in two words: interstate commerce. Due to the 2018 Farm Bill, hemp is traded across state borders and is beginning to show signs of commoditization with the latest spot price for smokable hemp down to $148 per pound. THC cannabis flower, however, fetches $1,100-$4,000 per pound (depending on the state) because it cannot be shipped across state lines.

Cannabis vape companies are experiencing a sales boom during the pandemic

TechCrunch

OUR TAKEAWAY

Consumers “locked-down” then “lit-up” as evidenced by record vaporizer device sales since the emergence of this global pandemic. The pandemic has accelerated demand for cannabis and accessory products and is straining an already-stressed supply chain.

A PBR seltzer spiked with THC hits shelves, aiming at the 'canna-curious'

NPR

OUR TAKEAWAY

In a recent Bengal Bite, we discussed the “power of authenticity” in branding. It remains to be seen whether or not existing consumer brands will be able to transition into cannabis in a way that resonates with consumers, but Pabst is bringing its Blue Ribbon reputation to the industry. Through a partnership with Pabst Labs, “PBR me ASAP” now comes with the option for THC during those nights out on the town.

Recreational cannabis brand and product expansion slow in US markets

Marijuana Business Daily

OUR TAKEAWAY

Cannabis companies are slowing the rollout of new brands and products in what might be the latest sign of market maturity in states that have legalized adult-use sales. This is good news for established cannabis brands as competition for shelf space declines while sales continue to grow.

OUR TAKEAWAY

The Science of Cannabis: October 16, 2020

From helping with insomnia to managing and mitigating migraines, studies are beginning to show the efficacy of cannabis and cannabinoids as medicine. Since Delta-9-THC (commonly referred to simply as “THC,” the most common active ingredient in cannabis) remains illegal at the federal level, industry and academia alike have only just begun to understand the “science of cannabis.” However, preliminary findings are highly encouraging and we are excited to see deeper studies into how cannabinoids can be harnessed to benefit patients in need. A survey of nearly 10,000 U.S. and Canadian migraine patients found that a third have tried medical cannabis to relieve their pain, and that 82% of those who have tried cannabis found it effective in providing pain relief.